Net Income

After a rough earnings report sent its stock tumbling, WEBTOON Entertainment heads to key investor conferences to pitch its long-term IP and creator vision.

A landmark draft permit advances a first-of-its-kind project in Louisiana, promising carbon-negative power, SAF, and a major economic boost for the region.

The green builder secured its Nasdaq status, but a sharp stock drop reveals market skepticism. Can its $78.5M pipeline convince cautious investors?

The pork producer reports a 10.7% sales jump and a 42% rise in adjusted EBITDA for 2025, rewarding investors with a new dividend.

As US energy demand soars, construction titan Clayco launches a new unit to build utility-scale solar and battery projects, betting on its integrated model.

On World Engineering Day, Zendure unveiled an AI-powered ecosystem and new solar storage, aiming to slash energy bills and challenge rivals in Europe.

Theolytics secures a prestigious €8 million EU grant to advance its unique cancer-killing virus, offering new hope for hard-to-treat ovarian cancer.

The VCT posts flat returns but rewards investors with a special dividend, announcing a new chair as it navigates a shifting regulatory landscape.

A new patented drug, budiodarone, aims to treat atrial fibrillation in heart failure patients, a group with few safe options. Is this the future of care?

TCL CSOT unveils 'Super Pixel' tech and groundbreaking IJP OLEDs at MWC, aiming to redefine display performance, efficiency, and manufacturing.

As a deadly superbug spreads, BioVersys's BV100 enters late-stage trials, backed by promising data and a novel scientific approach to combat resistance.

With record 2025 revenue and a dominant hold on the gene therapy market, Cryoport's strategic investments pave a path toward profitability.

Immunome announces stellar Phase 3 data for its desmoid tumor drug, varegacestat, and details a robust, well-funded ADC pipeline aimed at solid tumors.

A landmark Japan-international partnership aims to break down barriers and accelerate revolutionary stem cell treatments for patients worldwide.

Gold Strike Resources' transformational acquisition and $15M financing create a new powerhouse in Yukon's prolific Tombstone Gold Belt. A new gold rush?

Financial and tech giants take the stage to showcase real-world AI wins, as Pega issues an unprecedented satisfaction guarantee for its annual conference.

SaaS provider Planisware announces a €10M share repurchase after strong profits, tackling a puzzling stock slide and betting on its own future value.

A 10-year ad contract with JCDecaux will transform Denver's airport with cutting-edge digital media, funding its ambitious 100-million-passenger goal.

A major real estate trust's acquisition of a Watertown medical center highlights a national shift towards outpatient care and Boston's life sciences boom.

After a brush with delisting, Singapore's Orangekloud Technology has regained Nasdaq compliance, allowing it to focus on its AI-powered no-code platform.